2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine

C110H100ClN29O11 — CID 167687432

IUPAC2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine
SMILESCOc1nccc2c1N=C(Cc1nnc(-c3ccc(C)cc3)o1)C2.COc1nccc2c1N=C(Cc1nnc(-c3ccc(C)cc3)o1)C2.COc1nccc2c1N=C(Cc1nnc(-c3ccc(C)cc3)o1)C2.Cc1ccc(-c2nnc(CC3=Nc4ccnc(N5CCOCC5)c4C3)o2)cc1.Cc1ccc(-c2nnc(CC3=Nc4cnc(Cl)nc4C3)o2)cc1.Cc1ccc(-c2nnc(Nc3nc4c(N5CCOCC5)cncc4[nH]3)o2)cc1
InChIInChI=1S/C21H21N5O2.C19H19N7O2.3C18H16N4O2.C16H12ClN5O/c1-14-2-4-15(5-3-14)21-25-24-19(28-21)13-16-12-17-18(23-16)6-7-22-20(17)26-8-10-27-11-9-26;1-12-2-4-13(5-3-12)17-24-25-19(28-17)23-18-21-14-10-20-11-15(16(14)22-18)26-6-8-27-9-7-26;3*1-11-3-5-12(6-4-11)17-22-21-15(24-17)10-14-9-13-7-8-19-18(23-2)16(13)20-14;1-9-2-4-10(5-3-9)15-22-21-14(23-15)7-11-6-12-13(19-11)8-18-16(17)20-12/h2-7H,8-13H2,1H3;2-5,10-11H,6-9H2,1H3,(H2,21,22,23,25);3*3-8H,9-10H2,1-2H3;2-5,8H,6-7H2,1H3
InChIKeyWKOSWHKFQAAKHB-UHFFFAOYSA-N
MW2039.65 g/mol
LogP19.36
Rot. Bonds23

About 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine

2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine (PubChem CID 167687432) has the molecular formula C110H100ClN29O11 and a molecular weight of 2039.65 g/mol. Its IUPAC name is 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine.

Molecular Properties

Compound Name2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine
PubChem CID167687432
Molecular FormulaC110H100ClN29O11
Molecular Weight2039.65 g/mol
Exact Mass2037.78
IUPAC Name2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine
SMILESCOc1nccc2c1N=C(Cc1nnc(-c3ccc(C)cc3)o1)C2.COc1nccc2c1N=C(Cc1nnc(-c3ccc(C)cc3)o1)C2.COc1nccc2c1N=C(Cc1nnc(-c3ccc(C)cc3)o1)C2.Cc1ccc(-c2nnc(CC3=Nc4ccnc(N5CCOCC5)c4C3)o2)cc1.Cc1ccc(-c2nnc(CC3=Nc4cnc(Cl)nc4C3)o2)cc1.Cc1ccc(-c2nnc(Nc3nc4c(N5CCOCC5)cncc4[nH]3)o2)cc1
InChIInChI=1S/C21H21N5O2.C19H19N7O2.3C18H16N4O2.C16H12ClN5O/c1-14-2-4-15(5-3-14)21-25-24-19(28-21)13-16-12-17-18(23-16)6-7-22-20(17)26-8-10-27-11-9-26;1-12-2-4-13(5-3-12)17-24-25-19(28-17)23-18-21-14-10-20-11-15(16(14)22-18)26-6-8-27-9-7-26;3*1-11-3-5-12(6-4-11)17-22-21-15(24-17)10-14-9-13-7-8-19-18(23-2)16(13)20-14;1-9-2-4-10(5-3-9)15-22-21-14(23-15)7-11-6-12-13(19-11)8-18-16(17)20-12/h2-7H,8-13H2,1H3;2-5,10-11H,6-9H2,1H3,(H2,21,22,23,25);3*3-8H,9-10H2,1-2H3;2-5,8H,6-7H2,1H3
InChIKeyWKOSWHKFQAAKHB-UHFFFAOYSA-N
XLogP19.36
TPSA478.89 Ų
H-Bond Donors2
H-Bond Acceptors39
Rotatable Bonds23
Heavy Atoms151
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002039.65
LogP ≤ 519.36
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1039

Analyze 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine?
The IUPAC name of 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine (CID 167687432) is 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine.
What is the SMILES notation for 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine?
The canonical SMILES for 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine is COc1nccc2c1N=C(Cc1nnc(-c3ccc(C)cc3)o1)C2.COc1nccc2c1N=C(Cc1nnc(-c3ccc(C)cc3)o1)C2.COc1nccc2c1N=C(Cc1nnc(-c3ccc(C)cc3)o1)C2.Cc1ccc(-c2nnc(CC3=Nc4ccnc(N5CCOCC5)c4C3)o2)cc1.Cc1ccc(-c2nnc(CC3=Nc4cnc(Cl)nc4C3)o2)cc1.Cc1ccc(-c2nnc(Nc3nc4c(N5CCOCC5)cncc4[nH]3)o2)cc1.
What is the InChIKey of 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine?
The InChIKey is WKOSWHKFQAAKHB-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H21N5O2.C19H19N7O2.3C18H16N4O2.C16H12ClN5O/c1-14-2-4-15(5-3-14)21-25-24-19(28-21)13-16-12-17-18(23-16)6-7-22-20(17)26-8-10-27-11-9-26;1-12-2-4-13(5-3-12)17-24-25-19(28-17)23-18-21-14-10-20-11-15(16(14)22-18)26-6-8-27-9-7-26;3*1-11-3-5-12(6-4-11)17-22-21-15(24-17)10-14-9-13-7-8-19-18(23-2)16(13)20-14;1-9-2-4-10(5-3-9)15-22-21-14(23-15)7-11-6-12-13(19-11)8-18-16(17)20-12/h2-7H,8-13H2,1H3;2-5,10-11H,6-9H2,1H3,(H2,21,22,23,25);3*3-8H,9-10H2,1-2H3;2-5,8H,6-7H2,1H3.
What are the key properties of 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine?
2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine has a molecular weight of 2039.65 g/mol, XLogP of 19.36, 23 rotatable bonds, 2 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(2-chloro-7H-pyrrolo[3,2-d]pyrimidin-6-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole;tris(2-[(7-methoxy-3H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole);5-(4-methylphenyl)-N-(7-morpholin-4-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1,3,4-oxadiazol-2-amine;4-[2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]methyl]-3H-pyrrolo[3,2-c]pyridin-4-yl]morpholine is sourced from PubChem (CID 167687432), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).